HKDC1 promotes tumorigenesis and glycolysis in lung adenocarcinoma (LUAD) by regulating the AMPK-mTOR pathway, and targeting HKDC1 can delay LUAD progression [15,16]. Here, MTOR is linked to lung adenocarcinoma.